SomnoMed Limited (ASX:SOM)

SomnoMed Revenue

In the fiscal year ending June 30, 2026, SomnoMed had annual revenue of 114.53M AUD with 2.73% growth. SomnoMed had revenue of 53.82M in the half year ending June 30, 2026, with 15.64% growth. That makes SomnoMed the 24,328th largest company in the world by revenue and 424th in Australia.

• Revenue: 114.53M
• Revenue Growth: +2.73%
• P/S Ratio: 0.58
• Revenue / Employee: 381.77K
• Employees: 300
• Market Cap: 65.93M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Europe 63.51M 46.7%
• North America (Excl. North America (RSS Component)) 45.94M 33.8%
• Asia Pacific 26.47M 19.5%

Fiscal year ended Jun 30, 2026 See the full SomnoMed breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	114.53M	3.04M	2.73%
Jun 30, 2025	111.49M	19.84M	21.65%
Jun 30, 2024	91.65M	8.03M	9.61%
Jun 30, 2023	83.62M	11.04M	15.20%
Jun 30, 2022	72.58M	9.87M	15.75%

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 24, 2026

Data Sources Report a data error